Tickerplace logo

Tickerplace

Prescient Therapeutics Limited logo

PTXPrescient Therapeutics Limited

PTX Stock Price, Valuation & Chart | Prescient Therapeutics Limited

Compare
$0.070+0.00 (+0.00%)

At close · 02 Sept 2026, 06:10 am

Sector: HealthcarePTX intrinsic valuePTX calculated fair value vs priceWebsite
OverviewFinancialsDividendsRatios

PTX Historical price chart

PTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization71.50M
PE Ratio-6.73
EPS-0.01
Trading Volume832.04K
Today's High/Low0.07/0.07
Dividend Yield0.00
52 Week High/Low0.12/0.04
Shares Outstanding1.05B
PTX Financial Statement

PTX Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to PTX in the past 3 months.

PTX Analysis & performance metrics

PTX Company profile

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200,…

PTX Management team

Management
Steven Lee Yatomi-ClarkeCEO
MD, Chief Executive Officer & Director
Upaly BahadureCTO
Director of Clinical Affairs & Operations
Melanie Jaye Leydin B.Bus, C.A.CFO
Chief Financial Officer & Company Secretary
Terrence G. Chew
Chief Medical Officer
Total 4 executives

PTX Frequently asked questions

What is Prescient Therapeutics Limited (PTX) Stock Price?

Current stock price of Prescient Therapeutics Limited (PTX) stock is $0.070. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Prescient Therapeutics Limited (PTX) stock is 832.04K.

Last updated at 02 Sept 2026, 06:10 am.

Why is the Prescient Therapeutics Limited (PTX) stock price going up or down today?

The stock price of Prescient Therapeutics Limited (PTX) can change with earnings, company news, and overall market sentiment. Prescient Therapeutics Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Prescient Therapeutics Limited stock expensive at its current price?

Whether Prescient Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PTX on this page is -6.73. EPS on this page is -0.01. Compare those figures with peers and growth expectations before deciding if the current Prescient Therapeutics Limited price is justified.

How has the stock price of Prescient Therapeutics Limited (PTX) performed historically?

Historical performance for Prescient Therapeutics Limited (PTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PTX reacted to past earnings and market events.

Should I buy Prescient Therapeutics Limited (PTX) stock, at this price?

Buying Prescient Therapeutics Limited (PTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.